Back to the peptide atlas
NeurosciencePeptideNot FDA/EMA approved

DSIP

Sleep-regulation peptide

Also known as: Emideltide · Delta sleep-inducing peptide

No account · this device only

The essentials at a glance

Classification
Peptide · Neuroscience
Mechanism
Synthetic nonapeptide
Evidence
Preclinical
Status
Not FDA/EMA approved

Is studied in relation to sleep and stress regulation; evidence and safety data are insufficient.

Distinction: DSIP is primarily associated with sleep and stress regulation, unlike Epitalon, which is more focused on cellular ageing.

Evidence strengthPreclinical

Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.

Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

Research questions

Mechanism: DSIP

01

Sleep-regulation peptide

This studies how a peptide affects sleep phases and sleep onset in animal models, similar to testing the effect of a signal on the day-night rhythm. Sleep duration and sleep patterns are measured in the lab.

02

Anxiolytic signalling

This studies how a peptide affects stress and anxiety responses in animal models, similar to observing whether an animal stays calmer in an unfamiliar environment. Behavioural tests and stress hormone levels are measured.

03

Neuroendocrine signalling

This examines how the nervous system and hormone-producing glands communicate with each other, similar to a two-way phone line connecting the brain to distant organs. Researchers typically measure hormone levels in blood alongside markers of nervous system activity.

Simple example

Research-only molecule

Think of it like a component still being tested in a development workshop, not yet cleared for general use.

Research status means efficacy, dosing, and safety in humans are not yet conclusively established.

Community themes

How communities discuss it

Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.

Sleep optimization forums

Users compare subjectively perceived sleep quality and time to fall asleep after using different peptides, often with the help of sleep trackers. Everyday wearable data and forum reports do not replace controlled sleep-lab studies.

Biohacker and longevity forums

Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.

Source and purity discussion

Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.

Evidence boundary

Evidence and safety data are insufficient to support efficacy claims.

No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.

Primary sources

Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.